Peter J. Thornton insider trades: Avadel Pharmaceuticals (AVDL) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Peter reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 13, 2025 | AVDL | ↑ Buy | 10,000 | $8.04 | $80K | Direct | Jan 14, 2025 (1d) |
| May 27, 2022 | AVDL | ↑ Buy | 50,000 | $1.69 | $85K | Direct | May 31, 2022 (4d) |
| Sep 21, 2017 | AVDL | ↑ Buy | 5,155 | $9.74 | $50K | Direct | Sep 25, 2017 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other AVDL insiders
Open-market trades in the last 12 months
About Peter J. Thornton's insider trades
Peter J. Thornton is a director at Avadel Pharmaceuticals (AVDL). Since Sep 21, 2017, Peter has reported 3 open-market purchases worth $215K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (12 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AVDL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.